kombinationsbehandling med metformin var frekvensen af hypoglykæmi, der blev rapporteret for sitagliptin, den samme som for de patienter, der fik placebo.
In clinical trials of sitagliptin as monotherapy and sitagliptin as part of combination therapy with metformin, rates of hypoglycaemia reported with sitagliptin were similar to rates in patients taking placebo.